267
Participants
Start Date
March 31, 2001
Primary Completion Date
July 31, 2001
Study Completion Date
July 31, 2001
Buprenorphine transdermal patch
Buprenorphine transdermal patch 5, 10 or 20 mcg/h applied for 7-day wear.
Placebo to match BTDS
Placebo to match buprenorphine transdermal patch applied for 7-day wear.
ALL-TRIALS Clinical Research LLC, Winston-Salem
Cornerstone Research Care, High Point
The Arthritis Clinic, Charlotte
University Clinical Research Deland, DeLand
University Clinical Research Inc,, Pembroke Pines
Clinical Research of South Florida, Coral Gables
Gold Coast Research LLC, Tamarac
Gold Coast Research LLC, Plantation
Tampa Bay Medical Research Inc, Clearwater
Summit Research Solutions, Memphis
Southeastern Center for Headache and Pain, Crestview Heights
Private Practice, Chardon
Family Medicine Associates, Evansville
Pain Management and Rehabilitation, Terre Haute
Westside Family Medical Center PC, Kalamazoo
Clinical Research Management, New Berlin
Radiant Research, Austin
Wasatch Clinical Research, Salt Lake City
Hawthorne and York, Phoenix
Arizona Research Center Inc, Phoenix
Clinical Research Consultants Inc, Trumbull
Whiteabbey Health Centre, Newtownabbey
Antrim Coast Fundholding Group, Lame
Portglenone Health Centre, Portglenone
Garden Street Surgery, Magherafelt
Springhill Surgery, Bangor
Bennett Road Surgery, Keresley End
Little Common Surgery, Bexhill-on-Sea
Old Town Surgery, Bexhill-on-Sea
Roebuck House Surgery, Hastings
Leslie Surgery, Glenrothes
Valleyfield Health Centre, High Valleyfield
Townhead Health Centre, Glasgow
Castlemilk Health Centre, Glasgow
Ashvale Health Centre, Aldershot
The Academy Medical Practice, Coatbridge
Sanbury Health Centre Group Practice, Sunbury-on-Thames
Houston Surgery, Houston
The Burns Practice, Doncaster
Grosvenor Medical Centre, Royal Tunbridge Wells
Gables Medical Section, Coventry
The Ridge Medical Practice, Great Horton, Bradford
Collaborators (1)
Napp Pharmaceuticals Limited
INDUSTRY
Purdue Pharma LP
INDUSTRY